Compounds of the formula (I):
and bioprecursors and pharmaceutically acceptable salts thereof are described as β3-adrenoceptor agonists having anti-obesity, hypoglycaemic and related therapeutic utilities. Processes for their preparation are described as are compositions containing them.
式 (I):
及其
生物前体和药学上可接受的盐被描述为具有抗肥胖、降血糖和相关治疗作用的 β3-
肾上腺素受体激动剂。此外,还介绍了制备它们的工艺以及含有它们的组合物。